Kirsten Vonde

Principal Consultant, Granzer Regulatory Consulting & Services GmbH

Kirsten Vonde is listed as Principal Consultant, Granzer Regulatory Consulting & Services GmbH. Kirsten is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.

Compiled from published conference agendas; not yet confirmed by Kirsten. Is this you? Claim this profile.

Upcoming

Advanced Therapies Week 2027 19 January 2027 – 21 January 2027

• Regulator drop in Speaker · 19 January 2027
• Session 3: How to ensure the long-term future of advanced therapies for rare, ultra-rare and nano-rare diseases? Speaker · 19 January 2027
• Spotlight: Rare disease trial innovation Speaker · 19 January 2027

Spoke alongside

People who have shared a session with Kirsten at events on B2DB.

• Chris Juenger Director, Lead, North America Regulatory Science, Policy and Intelligence · CSL 1 shared session
• Deborah Hursh Consultant · Hursh Cell Therapy Consulting 1 shared session
• Mary Hames Board Member · CURE NDD 1 shared session
• Samar Mohanty President & CSO · Nanoscope Therapeutics 1 shared session